United States, Food and Drug Administration
Resource Information
The concept United States, Food and Drug Administration represents the subject, aboutness, idea or notion of resources found in University of San Diego Libraries.
The Resource
United States, Food and Drug Administration
Resource Information
The concept United States, Food and Drug Administration represents the subject, aboutness, idea or notion of resources found in University of San Diego Libraries.
- Label
- United States, Food and Drug Administration
- Authority link
- http://id.worldcat.org/fast/00549734
- Numeration
- Food and Drug Administration
- Source
- fast
- Subordinate unit
- Food and Drug Administration
217 Items that share the Concept United States, Food and Drug Administration
Context
Context of United States, Food and Drug AdministrationSubject of
No resources found
No enriched resources found
- When diets turn deadly : consumer safety and weight-loss supplements : hearing before the Oversight of Government Management, Restructuring, and the District of Columbia Subcommittee of the Committee on Governmental Affairs, United States Senate, One Hundred Seventh Congress, second session, July 31, 2002
- "Just mayo" just isn't warns FDA
- A delicate balance : FDA and the reform of the medical device approval process : hearing before the Special Committee on Aging, United States Senate, One Hundred Twelfth Congress, first session, Washington, DC, April 13, 2011
- A review of the administration's fiscal year 2006 health care priorities : hearing before the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, February 17, 2005
- A system overwhelmed : the avalanche of imported, counterfeit, and unapproved drugs into the U.S. : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, first session, June 24, 2003
- Acceptable risks : politics, policy, and risky technologies
- Access to unapproved drugs : FDA policies on compassionate use and emergency use authorization
- Advisory Committee on the Food and Drug Administration : final report : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, first session, on reviewing the Advisory Committee on the Food and Drug Administration report on the current state of FDA, and its recommendations to strengthen FDA, May 15, 1991
- Agriculture Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 1992 : P.L. 102-142, 105 Stat. 878, October 28, 1991
- Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 1993 : P.L. 102-341, 106 Stat. 873, August 14, 1992
- Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 1994 : P.L. 103-111, 107 Stat. 1046, October 21, 1993
- Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations for 1998 : hearings before a subcommittee of the Committee on Appropriations, House of Representatives, One Hundred Fifth Congress, first session
- Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations bill, 2016 : report together with minority views (to accompany H.R. 3049)
- Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations bill, 2017 : report together with dissenting and additional views (to accompany H.R. 5054)
- Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations bill, 2018 : report together with additional views (to accompany H.R. 3268)
- Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations bill, 2019 : report (to accompany S. 2976)
- Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations bill, 2020 : report together with minority views (to accompany H.R. 3164)
- Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for 1993 : hearings before a subcommittee of the Committee on Appropriations, House of Representatives, One Hundred Second Congress, second session
- Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for 1994 : dietary supplements : hearings before a subcommittee of the Committee on Appropriations, House of Representatives, One Hundred Third Congress, first session
- Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for 1994 : hearings before a subcommittee of the Committee on Appropriations, House of Representatives, One Hundred Third Congress, first session
- Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for 1999 : hearings before a subcommittee of the Committee on Appropriations, House of Representatives, One Hundred Fifth Congress, second session
- Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for 2010 : hearings before a Subcommittee of the Committee on Appropriations, House of Representatives, One Hundred Eleventh Congress, first session
- Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for 2011 : hearings before a Subcommittee of the Committee on Appropriations, House of Representatives, One Hundred Eleventh Congress, second session
- Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for 2020 : hearings before a Subcommittee of the Committee on Appropriations, House of Representatives, One Hundred Sixteenth Congress, first session
- Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for fiscal year 2011 : hearings before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Eleventh Congress, second session on S. 3606, an act making appropriations for Agriculture, Rural Development, Food and Drug Administration, and related agencies programs for the fiscal year ending September 30, 2011, and for other purposes
- Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for fiscal year 2014 : hearings before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Thirteenth Congress, first session on H.R. 2410/S. 1244, an act making appropriations for Agriculture, Rural Development, Food and Drug Administration, and related agencies programs for the fiscal year ending September 30, 2014, and for other purposes
- Agriculture, Rural Development, and related agencies appropriations for fiscal year 2006 : hearings before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Ninth Congress, first session, on H.R. 2744, an act making appropriations for Agriculture, Rural Development, Food and Drug Administration, and related agencies programs for the fiscal year ending September 30, 2006, and for other purposes
- Agriculture, rural development, and related agencies appropriations for fiscal year 2004 : hearings before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Eighth Congress, first session, on H.R. 2673/S. 1427, an act making appropriations for agriculture, rural development, Food and Drug Administration, and related agencies programs for the fiscal year ending September 30, 2004, and for other purposes : Department of Agriculture, Department of Health and Human Services: Food and Drug Administration, nondepartmental witnesses
- Agriculture, rural development, and related agencies appropriations for fiscal year 2005 : hearings before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Eighth Congress, second session, on H.R. 4766/S. 2803, an act making appropriations for agriculture, rural development, Food and Drug Administration, and related agencies programs for the fiscal year ending September 30, 2005, and for other purposes : Department of Agriculture, Department of Health and Human Services: Food and Drug Administration, nondepartmental witnesses
- Anesthesia machine failures : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-eighth Congress, second session, September 26, 1984
- Banning of the drug Laetrile from interstate commerce by FDA : hearing before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, Ninety-fifth Congress, first session ... July 12, 1977
- Biosimilar implementation : a progress report from FDA : hearing before the Subcommittee on Primary Health and Retirement Security of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, first session ... September 17, 2015
- Building a 21st century FDA : proposals to improve drug safety and innovation : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, second session, on examining proposals to improve drug safety and innovation, and S. 3807, to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, November 16, 2006
- CRS issue statement on agriculture appropriations
- Cancer patient access to unapproved treatments : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, February 29, 1996
- Clinical trial subjects : adequate FDA protections? : hearing before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, April 22, 1998
- Commission on the Federal Drug Approval Process : final report
- Consumer protection at the Food and Drug Administration : hearing before the Ad Hoc Subcommittee on Consumer and Environmental Affairs of the Committee on Governmental Affairs, United States Senate, One Hundred Second Congress, first session, September 27, 1991
- Continuing concerns over imported pharmaceuticals : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 7, 2001
- Council on Competitiveness and FDA plans to alter the drug approval process at FDA : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, March 19, 1992
- Delays in the FDA's food additive petition process and GRAS affirmation process : hearings before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, June 22 and 29, 1995
- Developing a comprehensive response to food safety : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining developing a comprehensive response to food safety problems, December 4, 2007
- Dietary Supplement Health and Education Act : is the FDA trying to change the intent of Congress? : hearing before the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, first session, March 25, 1999
- Diminished capacity : can the FDA assure the safety and security of the nation's food supply? : Hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session
- Discussion draft of the Food and Drug Administration Globalization Act legislation : device and cosmetic safety provisions : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, May 14, 2008
- Drug Industry Antitrust Act : hearings before the Antitrust Subcommittee (Subcommittee No. 5) of the Committee on the Judiciary, House of Representatives, Eighty-seventh Congress, second session, on H.R. 6245, a bill to amend and supplement the antitrust laws with respect to the manufacture and distribution of drugs, and for other purposes, May 17, 18, 23, and 24, 1962
- Drug compounding : FDA authority and possible issues for Congress
- Drug lag : hearing before the Subcommittee on Natural Resources, Agriculture Research, and Environment of the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, first session, September 16, 1981
- Drug regulation reform--oversight : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session .
- Drug safety : a side-by-side comparison of bills in the 110th Congress
- Drug safety : most drugs withdrawn in recent years had greater health risks for women
- Drug safety and effectiveness : issues and action options after FDA approval
- Drug safety: COVID-19 complicates already challenged FDA foreign inspection program : testimony before the Committee on Finance, U.S. Senate
- Drugs and biologics : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives ; One Hundred Fourth Congress, first session ; May 25, 1995 : A consumer's perspective ; June 19, 1995 : FDA review process
- Ensuring drug safety : where do we go from here? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the Food and Drug Administration's process of ensuring drug safety, March 3, 2005
- Evaluating the effectiveness of the Food And Drug Administration Modernization Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, May 3, 2001
- FDA Advisory Committee conflict of interest
- FDA Export Reform and Enhancement Act of 1995 : hearing before the Subcommittee on Aging of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, first session on S. 593 ... July 13, 1995
- FDA FY2009 appropriations
- FDA Modernization Act : implementation of the law : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, first session on examining the Food and Drug Administration Modernization Act (P.L. 105-115), focusing on provisions on pharmaceuticals and medical devices, October 21, 1999
- FDA and the medical device industry : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, February 26, 1990
- FDA and the medical device industry : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, March 25 and June 3, 1992
- FDA and the veterinarian
- FDA authority to oversee private laboratories that analyze imported FDA-regulated food
- FDA final rule restricting the sale and distribution of cigarettes and smokeless tobacco
- FDA guidance regarding the promotion of off-label uses of drugs : legal issues
- FDA human medical product user fee programs : in brief
- FDA in the twenty-first century : the challenges of regulating drugs and new technologies
- FDA legislation in the 110th Congress : a guide to S. 1082 and H.R. 2900
- FDA medical product approvals : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 8, 1995
- FDA medical product user fee reauthorization : in brief
- FDA mismanagement : regulation of soft contact lenses : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives ; Ninety-seventh Congress, first session ; May 29 and June 2, 1981
- FDA oversight : medical devices : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-seventh Congress, second session, July 16, 1982
- FDA oversight--food inspection : hearings, Ninety-second Congress, first session
- FDA policy on home drug testing kits : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, February 6, 1997
- FDA proposals to ease restrictions on the use and sale of experimental drugs : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One hundredth Congress, first session, April 29, 1987
- FDA proposals to permit the use of disease-specific health claims on food labels : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, first session, December 10, 1987
- FDA regulation of blood safety : notification, recall, and enforcement practices : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, June 5, 1997
- FDA regulation of cosmetics and personal care products
- FDA regulation of medical devices
- FDA regulation of medical devices, including the status of breast implants : joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 1, 1995
- FDA regulation of ribavirin : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, first session, May 28, 1987
- FDA regulation of soft contact lenses : hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session, December 12, 1980
- FDA regulation of the new drug "Serc" : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, second session. September 25, 1972
- FDA regulation of tobacco products
- FDA regulation of tobacco products : a policy and legal analysis
- FDA user fees 2012 : issues related to accelerated approval, medical gas, antibiotic development, and downstream pharmaceutical supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, March 8, 2012
- FDA user fees and the regulation of drugs, biologics, and devices : comparative analysis of S. 3187 and H.R. 5651
- FDA's authority to ensure that drugs prescribed to children are safe and effective
- FDA's authority to regulate drug compounding : a legal analysis
- FDA's continuing failure to regulate health claims for foods : hearings before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred First Congress, first session, October 31 and November 9, 1989
- FDA's drug and device review process : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 6, 1992
- FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session
- FDA's generic drug enforcement and approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives ; One Hundred Second Congress, first session ; March 7 and June 5, 1991
- FDA's prescription to over-the-counter drug switch : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-eighth Congress, first session on the Food and Drug Administration's policies and procedures in switching drugs from prescription to over-the-counter status, June 6, 1983
- FDA's regulation of Carcinogenic additives : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One hundredth Congress, first session, June 24, 1987
- FDA's regulation of Zomax : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, first session, April 26 and 27, 1983
- FDA's regulation of food imports : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, first session, June 16, 1993
- FDA's regulation of the dietary supplement L-tryptophan : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, first session, July 18, 1991
- FDA's regulation of the drug "triazure" : hearing before a Subcommittee of the Committee on Government Operations, House of Representatives, Ninety-fourth Congress, second session. October 27, 1976
- FDA's regulation of the marketing of unapproved new drugs : the case of E-Ferol vitamin E aqueous solution : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, second session, May 4, 1984
- FDA's regulation of the new drug Suprol : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, first session, May 27, 1987
- FDA's regulation of the new drug Versed : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, May 5 and 10, 1988
- FDA's role in protecting the public health : examining FDA's review of safety and efficacy concerns in anti-depressant use by children ; hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives ; One Hundred Eighth Congress, second session ; September 23, 2004
- FDA's role in the evaluation of Avandia's safety : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, June 6, 2007
- FY2016 agriculture and related agencies appropriations : in brief
- FY2016 appropriations : selected federal food safety agencies
- FY2017 agriculture and related agencies appropriations : in brief
- Federal food, drug, and cosmetic act : with amendments
- Federal protection for human research subjects : an analysis of the Common Rule and its interactions with FDA regulations and the HIPAA privacy rule
- Food and Drug Administration : revenue information on certain companies participating in the Medical Device User Fee Program
- Food and Drug Administration FY2011 budget and appropriations
- Food and Drug Administration Modernization Act of 1997--the provisions
- Food and Drug Administration Revitalization Act : P.L. 101-635, 104 Stat. 4583, November 28, 1990
- Food and Drug Administration act : hearing, Ninety-second Congress, second session, on H.R. 15315 Ninety-second Congress, second session, on H.R. 15315 ... June 9, 1972
- Food and Drug Administration appropriations for FY2010
- Food and Drug Administration management concerns : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, second session, April 1, 1998
- Food and Drug Administration practice and procedure, 1975 : joint hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate; Ninety-fourth Congress, first session; on examination of the history of Food and Drug Administration's regulatory efforts with the Dalkon Shield, and the procedures they use in considering various drugs given to animals that may be consumed by the American people; January 28, 1975--the Dalkon Shield; January 29, 1975--Bureau of Veterinary Medicine and Bureau of Foods
- Food and Drug Administration practice and procedure, 1976 : joint hearing before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-fourth Congress, second session ... July 20, 1976
- Food and Drug Administration's compliance with the Inflation Adjustment Act
- Food and Drug Administration's food labeling regulation, its effect on small business : hearings before the Subcommittee on Special Small Business Problems of the Committee on Small Business, House of Representatives, Ninety-fifth Congress, second session, Washington, D.C., July 13, August 3, 1977, and March 15, 1978
- Food and Drug Administration's regulation of dietary supplements : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Third Congress, first session, July 20, 1993
- Food and Drug Administration's review process for products to treat rare diseases and neglected tropical diseases : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Eleventh Congress, second session, special hearing, June 23, 2010, Washington, D.C
- Food and Drug enforcement standards for medical devices : joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, September 14, 1995
- Food and cosmetic provisions of the Food and Drug Administration Globalization Act discussion draft legislation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, April 24, 2008
- Food and drug administration : its programs--problems--resources
- Food import inspection : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session, July 19 and September 28, 1989
- Food recalls and other FDA administrative enforcement actions
- Food safety : foodborne illness and selected recalls of FDA-regulated foods
- Food safety issues : FDA judicial enforcement actions
- Food, Drug, Cosmetic, and Device Enforcement Authorities Act : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, second session, on S. 2135 ... May 19, 1992
- Food, drug, cosmetic, and device enforcement amendments : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2597, a bill to amend the Federal Food, Drug, and Administration, July 17, 1991
- Hard to swallow : FDA enforcement program for imported food : a staff report
- Hollow government : the Food and Drug Administration : hearing before the Committee on Governmental Affairs, United States Senate, One Hundred Second Congress, first session, July 25, 1991
- How FDA approves drugs and regulates their safety and effectiveness
- How accurate is the FDA's monitoring of supplements like ephedra? : hearing before the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, first session, May 27, 1999
- Impact of chemical and related drug products and Federal regulatory processes : hearings before the Subcommittee on Dairy and Poultry of the Committee on Agriculture, House of Representatives, Ninety-fifth Congress, first session, May 23, 24, and 25, 1977
- Implementation of the Food and Drug Administration Modernization Act of 1997 : hearing before the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, second session, October 7, 1998
- Imported drugs : U.S.-EU (European Union) mutual recognition agreement on drug inspections : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, second session, October 2, 1998
- Innovation in America : opportunities and obstacles : hearing before the Subcommittee on Competitiveness, Innovation, and Export Promotion of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Eleventh Congress, second session, June 22, 2010
- Legal issues associated with FDA standards of identity : in brief
- Legislative changes and administrative improvements should be considered for FDA to better protect the public from adulterated food products : report to the Chairman, Subcommittee on Oversight and Investigations, House Committee on Energy and Commerce
- Medicaid Pharmaceutical Home Act of 2018 : report together with additional views (to accompany H.R. 5808) (including cost estimate of the Congressional Budget Office)
- Medical device regulation : the FDA's neglected child : an oversight report on FDA implementation of the Medical Device Amendments of 1976 : report of the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, U.S. House of Representatives
- Medical device user fees : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session, on H.R. 4728, a bill to amend the Federal Food, Drug, and Cosmetic Act to authorize a device application fee, and for other purposes, July 14, 1994
- Medical devices : technological innovation and patient/provider perspectives : hearing before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, May 30, 1997
- Medical letter on the CDC & FDA
- Medical technology development and commercialization : hearing before the Subcommittee on Technology of the Committee on Science, U.S. House of Representatives, One Hundred Fourth Congress, first session, November 2, 1995
- Mercury in medicine--are we taking unnecessary risks? : hearing before the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, second session, July 18, 2000
- Naked reverse : Secretary Sullivan's rescission of his delegation of investigative authority to the Inspector General : a staff report
- Nomination : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, second session on Mark McClellan, of the District of Columbia, to be Commissioner of Food and Drugs, October 7, 2002
- Nomination : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fifth Congress, second session, on Jane E. Henney, of New Mexico, to be Commissioner of Food and Drugs, Department of Health and Human Services, September 2, 1998
- Nomination of Andrew von Eschenbach and Paul DeCamp : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, second session, on Andrew von Eschenbach, of Texas, to be Commissioner of Food and Drugs, Department of Health and Human Services ; Paul DeCamp, of Virginia, to be Administrator of the Wage and Hour Division, Department of Labor, August 1, 2006
- Off-label drug use and FDA review of supplemental drug applications : hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, September 12, 1996
- Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018 : report together with additional views (to accompany H.R. 5333) (including cost estimate of the Congressional Budget Office)
- Oversight of FTC's shared responsibilities : hearing before the Subcommittee on Transportation and Hazardous Materials of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, concerning advertising and labeling issues with the Bureau of Alcohol, Tobacco, and Firearms, the Environmental Protection Agency, and the Food and Drug Administration, November 21, 1991
- Oversight of NIH and FDA : bioethics and the adequacy of informed consent : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, May 8, 1997
- Oversight of the Food and Drug Administration's progress in reducing unnecessary paperwork burdens upon small business : hearing before the Subcommittee on Government Programs of the Committee on Small Business, House of Representatives, One Hundred Fourth Congress, second session, Washington, DC, July 24, 1996
- Oversight of the new drug review process and FDA's regulation of Merital : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, second session, May 22, 1986
- Patient access to alternative treatments : beyond the FDA : hearings before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, February 4 and 12, 1998
- Patient safety and anticancer drugs, 1983 : hearing before the Committee on labor and Human Resources, United States Senate, Ninety-eighth Congress, first session on examination of the effects of anticancer drugs in the treatment of cancer patients, June 23, 1983
- Penalties for illegal activities in the approval of drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House and Representatives, One Hundred First Congress, second session, on H.R. 4810 ... June 28, 1990
- Pipeline drugs : proposed remedies for relief in the Drug Patent Term Restoration Review Procedure Act of 1999 : hearing before the Committee on the Judiciary, United States Senate, One Hundred Sixth Congress, first session, on S. 1172 ... August 4, 1999
- Preclinical and clinical testing by the pharmaceutical industry, 1975[-1976] : joint hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-fourth Congress, second session, on examination of the process of drug testing and FDA's role in the regulation and conditions under which such testing is carried out
- Preclinical and clinical testing by the pharmaceutical industry, 1979 : hearing before the Subcommittee on Health and Scientific Research of the Committee on Labor and Human Resources, United States Senate, Ninety-sixth Congress, first session, on examination of the process of drug testing and FDA's role in the process, October 11, 1979
- President's budget blueprint seeks changes for public health service agencies
- Problems with FDA monitoring for animal drug residues : is our milk safe? : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, August 5, 1992
- Problems with FDA's regulation of the antiarrhythmic drugs Tambocor and Enkaid : hearing before the Human Resources and Intergovernmental Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, first session, April 10, 1991
- Promotion of drugs and medical devices for unapproved uses : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, first session, June 11, 1991
- Punitive damages : tort reform and FDA defenses : hearings before the Committee on the Judiciary, United States Senate, One Hundred Fourth Congress, first session, on S. 671 ... S. 672 ... April 4 and July 26, 1995
- Quality of scientific evidence in FDA regulatory decisions : the adoption of an antismoking warning in oral contraceptive pill labeling : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-fifth Congress, second session, October 4, 1978
- RU 486 : the import ban and its effect on medical research : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred First Congress, second session, Washington, DC, November 19, 1990
- Raising health awareness through examining benign brain tumor cancer, alpha one, and breast implant issues : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, November 15, 2001
- Reauthorization of the Prescription Drug User Fee Act and FDA reform : hearing before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, April 23, 1997
- Recall procedures of the Food and Drug Administration : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, first session. March 29, 1971
- Regulating innovation : FDA's medical device approval process : hearing before the Subcommittee on Investigations and Oversight of the Committee on Science, Space, and Technology, U.S. House of Representatives, One Hundred Third Congress, first session, September 17, 1993
- Regulatory exclusivity reform in the 115th Congress
- Regulatory policies of the Food and Drug Administration : Hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-first Congress, second session, June 9, 1970
- Reinventing regulation of drugs and medical devices
- Reinventing the regulation of cancer drugs : accelerating approval and expanding access
- Reinventing the regulation of drugs made from biotechnology
- Reputation and power : organizational image and pharmaceutical regulation at the FDA
- Restoring FDA's ability to keep America's families safe : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, second session, on examining the U.S. Food and Drug Administration, focusing on its ability to ensure the safety of food and the drug supply in the United States, April 24, 2008
- Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012
- Revitalizing new product development from clinical trials through FDA review : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, second session, on S. 1477 ... February 21, 1996
- Riegel v. Medtronic, Inc. : federal preemption of state tort law regarding medical devices with FDA premarket approval
- Role of commissioner of food and drugs : hearing before the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, first session, on examining the role of the current commissioner of the Food and Drug Administration, March 6, 1991
- Safety of the U.S. food supply : continuing concerns over the Food and Drug Administration's food-recall process : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, January 19, 2018
- Selected resources on federal oversight of compounding pharmacies
- Senate confirmation of the FDA commissioner ; and reauthorization of research activities by ADAMHA : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, second session, on H.R. 3909 ... March 6, 1986
- Soft contact lens solutions : oversight of FDA : hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representative, Ninety-sixth Congress, second session, July 1, 1980
- Sulfites : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, March 27, 1985
- The FDA FY2009 budget
- The FDA and the future of American biomedical and food industries : hearing of the Committee on Labor and Human Resources, United States Senate ; One Hundred Fourth Congress, first session ; on examining activities of the Food and Drug Afministration focusing on the challenges and opportunities facing the pharmaceutical, biotech, medical device, and food industries, and FDA's regulation of these industries ; April 5 and 6, 1995
- The FDA medical device user fee program : MDUFA IV reauthorization
- The FDA medical device user fee program : MDUFA IV reauthorization
- The FDA's authority to recall products
- The FDA's regulation of silicone breast implants : a staff report
- The Food & drug letter
- The Food and Drug Administration : budget and statutory history, FY1980-FY2007
- The Food and Drug Administration's critical mission and challenges for the future : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, May 1, 2007
- The Impact of the Food and Drug Administration on our society : a fiftieth anniversary panorama
- The Prescription Drug User Fee Act : history through the 2007 PDUFA IV reauthorization
- The law of biologic medicine : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, second session, June 23, 2004
- The need for FDA regulatory reform to protect the health and safety of Americans : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, June 9, 1995
- The regulation of animal drugs by the Food and Drug Administration : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, first session, July 24 and 25, 1985
- The regulation of new drugs by the Food and Drug Administration : the new drug review process : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-seventh Congress, second session, August 3 and 4, 1982
- The regulation of pharmaceuticals : balancing the benefits and risks
- The risks of prescription drugs
- To assess the impact of proposed FDA user fees on small business : hearing before the Committee on Small Business, United States Senate, One Hundred First Congress, first session ... June 13, 1989
- Tobacco legislation and the Food and Drug Administration and smokeless tobacco issues in the proposed settlement : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Fifth Congress, second session, March 17, 1998
- U.S.-South Korea beef dispute : issues and status
- U.S.-South Korea beef dispute : negotiations and status
- U.S.-South Korea beef dispute : negotiations and status
- Use of advisory committees by the Food and Drug Administration : hearings before a subcommittee of the Committee on Government Operations, House of Representatives
- Use of advisory committees by the Food and Drug Administration : hearings before a subcommittee of the Committee on Government Operations, House of Representatives ; Ninety-third Congress, second session[-Ninety-fourth Congress, first session]
- User fees for prescription drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, August 10, 1992
Embed
Settings
Select options that apply then copy and paste the RDF/HTML data fragment to include in your application
Embed this data in a secure (HTTPS) page:
Layout options:
Include data citation:
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.sandiego.edu/resource/u8AYUQ28YRY/" typeof="CategoryCode http://bibfra.me/vocab/lite/Concept"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.sandiego.edu/resource/u8AYUQ28YRY/">United States, Food and Drug Administration</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.sandiego.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.sandiego.edu/">University of San Diego Libraries</a></span></span></span></span></div>
Note: Adjust the width and height settings defined in the RDF/HTML code fragment to best match your requirements
Preview
Cite Data - Experimental
Data Citation of the Concept United States, Food and Drug Administration
Copy and paste the following RDF/HTML data fragment to cite this resource
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.sandiego.edu/resource/u8AYUQ28YRY/" typeof="CategoryCode http://bibfra.me/vocab/lite/Concept"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.sandiego.edu/resource/u8AYUQ28YRY/">United States, Food and Drug Administration</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.sandiego.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.sandiego.edu/">University of San Diego Libraries</a></span></span></span></span></div>
